tiprankstipranks
Spectral Medical (TSE:EDT)
TSX:EDT

Spectral Medical (EDT) Stock Price & Analysis

15 Followers

EDT Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.23 - C$0.67
Previous CloseC$0.44
Volume500.00
Average Volume (3M)104.27K
Market Cap
C$122.57M
Enterprise ValueC$118.20M
Total Cash (Recent Filing)C$5.03M
Total Debt (Recent Filing)C$656.00K
Price to Earnings (P/E)-7.8
Beta-0.45
May 10, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding278,576,261
10 Day Avg. Volume49,925
30 Day Avg. Volume104,269
Standard Deviation0.17
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-11.99
Price to Sales (P/S)73.55
Price to Cash Flow (P/CF)-9.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

42.55%0.00%<0.01%57.44%
42.55%
Insiders
<0.01% Other Institutional Investors
57.44% Public Companies and
Individual Investors

EDT FAQ

What was Spectral Medical’s price range in the past 12 months?
Spectral Medical lowest stock price was C$0.23 and its highest was C$0.67 in the past 12 months.
    What is Spectral Medical’s market cap?
    Currently, no data Available
    When is Spectral Medical’s upcoming earnings report date?
    Spectral Medical’s upcoming earnings report date is May 10, 2024 which is in 21 days.
      How were Spectral Medical’s earnings last quarter?
      Spectral Medical released its earnings results on Mar 28, 2024. The company reported -C$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.03.
        Is Spectral Medical overvalued?
        According to Wall Street analysts Spectral Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Spectral Medical pay dividends?
          Spectral Medical does not currently pay dividends.
          What is Spectral Medical’s EPS estimate?
          Spectral Medical’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Spectral Medical have?
          Spectral Medical has 278,576,260 shares outstanding.
            What happened to Spectral Medical’s price movement after its last earnings report?
            Spectral Medical reported an EPS of -C$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Spectral Medical?
              Currently, no hedge funds are holding shares in TSE:EDT
              ---

              Spectral Medical Stock Smart Score

              Company Description

              Spectral Medical

              Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include Endotoxin Activity Assay (EAA), Toraymyxin, and proprietary reagents. The EAA is use for the diagnostic of endotoxin activity in human whole blood. The Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Resmed
              Bio-Techne
              Baxter International
              Spectral Medical
              Merit Medical Systems
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis